22 November 2019
Access to toxicity study reports and protection of commercial interests
www.twobirds.com/en/news/articles/2019/uk/access-to-toxicity-study-reports-and-protection-of-commercial-interests

Gerard Hogan, Advocate General at the Court of Justice of the European Union (“CJEU”) recently delivered an opinion in the pending case between MSD Animal Health Innovation (“MSD”), Intervet international (“Intervet”) ...

08 May 2019
Manufacturing and stockpiling waiver set to limit rights of holders of SPCs for medicines
www.twobirds.com/en/news/articles/2019/global/manufacturing-and-stockpiling-waiver-set-to-limit-rights-of-holders-of-spcs-for-medicines

On 17 April 2019, the European Parliament approved, by a large majority, an amendment of the Regulation on Supplementary Protection Certificates ("SPCs").

05 February 2019
"Effective enforcement of EU competition rules in the pharmaceutical law remains a matter of high priority…"
www.twobirds.com/en/news/articles/2019/global/effective-enforcement-of-eu-competition-rules-in-pharmaceutical-law

So notes the Commission's report on competition enforcement in the pharmaceutical sector (2009-2017) published at the end of January 2019.

02 December 2019
The French Health Data Hub becomes reality
www.twobirds.com/en/news/articles/2019/france/the-french-health-data-hub-becomes-reality

The French Health Data Hub was born officially with the publication on 30 November 2019 of a ministerial decision (arrêté).

02 July 2019
Transfer of value: amendments to the French “anti-gift” provisions by the draft Health Act
www.twobirds.com/en/news/articles/2019/global/transfer-of-value-amendments-to-the-french-anti-gift-provisions-by-the-draft-health-act

The French so-called “anti-gift” provisions strictly frame the conditions under which companies in the health sector are allowed to provide advantages, in cash or in kind, to healthcare professionals ("HCPs”)

15 November 2018
Supreme Court defines plausibility in the context of sufficiency
www.twobirds.com/en/news/articles/2018/uk/supreme-court-defines-plausibility-in-the-context-of-sufficiency

A majority postulates a new "outward presentation test" to deal with the infringement of second medical use patents.

30 September 2019
Bird & Bird secures win in preliminary injunction patent case before the Düsseldorf Courts
www.twobirds.com/en/news/articles/2019/germany/bird-and-bird-secures-win-in-preliminary-injunction-patent-case-before-the-dusseldorf-courts

On September 26, 2019, the Higher Regional Court of Düsseldorf confirmed on appeal that Teva Pharmaceutical Industries Ltd. (“Teva”) – one of Bird & Bird’s key clients – is entitled to a preliminary injunction against ...

24 May 2019
Can CRISPR save the Cavendish?
www.twobirds.com/en/news/articles/2019/global/can-crispr-save-the-cavendish

The world's most popular banana is dying. Scientists are using the gene-editing mechanism CRISPR to try and save it from extinction.

15 February 2021
A vaccine for COVID-19: risks and liabilities from an international perspective
www.twobirds.com/en/news/articles/2020/netherlands/a-vaccine-for-covid-19-risks-and-liabilities-in-international-perspective

As the development of vaccines against COVID-19 is progressing, the question becomes urgent who will be liable if a vaccine is marketed and will cause unexpected adverse effects as a result of the requested speed and ...

23 April 2020
COVID-19: Our series of regulatory legislation trackers for the Life Sciences & Healthcare industry
www.twobirds.com/en/news/articles/2020/global/covid-19-our-series-of-regulatory-legislation-trackers-for-the-life-sciences-and-healthcare-industry

COVID-19 presents an unprecedented challenge to the global life sciences industry. Members of our International Life Sciences & Healthcare team, lawyers who have a wealth of hands-on experience and strong relationships ...